Delivery Order SPE2DE23D0008-SPE2D626F63G2
- Not listed
- The U.S. Department of Defense Medical Supply Chain, operating through the Defense Logistics Agency Troop Support Medical, awarded a $2,814 fixed-price delivery order with economic price adjustment to Allergan USA Inc. for Natrelle Inspira SCX 800cc breast implants. The delivery order, issued on September 11, 2025, with an ultimate completion date of September 25, 2025, represents a child order under one of Allergan's existing Indefinite Delivery Vehicles—specifically a $13.5 million IDV for...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,614.00 fixed-price delivery order on September 19, 2025, for Natrelle Inspira SCM 445CC breast implants through the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract carries an ultimate completion date of September 23, 2025, and will be performed in Irvine, California. This delivery order was issued without set-aside designation, reflecting Allergan's sole-source supplier status for specialized...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $2,814 delivery order for Natrelle Inspira SCF 485CC breast implants by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment was awarded on December 9, 2025, with an ultimate completion date of December 11, 2025, and will be performed in Irvine, California. The award was made without a set-aside designation, reflecting Allergan's status as the sole-source...
- On November 12, 2025, the Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,614.00 to Allergan USA Inc. for Natrelle Inspira SCF 325CC breast implants. The contract is a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Allergan's status as a sole-source provider of these specialized medical devices. The order is expected to be completed by November 18, 2025, with performance to be...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,021.00 fixed-price delivery order with economic price adjustment for Natrelle Inspira SCM 375CC breast implants on July 22, 2025. This delivery order, which is a child contract under a larger Indefinite Delivery Vehicle, will be performed in Irvine, California and is scheduled for completion by July 24, 2025. The contract was awarded without set-aside designation by the Medical Supply Chain division of the Defense Logistics...
- The U.S. Department of Defense Medical Supply Chain division awarded a $2,814.00 fixed-price delivery order to Allergan USA Inc. (a subsidiary of AbbVie Inc.) on May 30, 2025, for Natrelle Inspira SCF 385CC breast implants with an ultimate completion date of May 30, 2025. The delivery order will be performed in Irvine, California, and includes economic price adjustment provisions. This award was made without a set-aside designation, reflecting Allergan's status as the sole source for this...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,814 fixed-price delivery order for Natrelle Inspira SCM 330cc breast implants by the Defense Logistics Agency (DLA) Troop Support Medical on September 5, 2025. This delivery order, which has no set-aside designation, is a child contract stemming from one of Allergan's larger Indefinite Delivery Vehicles—specifically the $13.5 million Natrelle breast implants and surgical devices IDV established on December 8, 2022. The order is...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,850 fixed-price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical on November 6, 2025, for Natrelle Inspira SSM 405CC breast implants. The contract, which represents a child delivery order under a larger Indefinite Delivery Vehicle (IDV), is scheduled for completion by November 24, 2025, and will be performed at the contractor's facility in Irvine, California. The award carries no set-aside designation,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,228.00 fixed-price delivery order with economic price adjustment on December 9, 2025, for Natrelle Inspira SCF 385CC breast implants. The contract, which is expected to be completed by December 11, 2025, will be performed at Allergan's facility in Irvine, California. This delivery order carries no set-aside designation and is funded through the Medical Supply Chain division of the Defense Logistics Agency (DLA) Troop Support...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, with an ultimate completion date of July 24, 2025. The contract covers the supply of Natrelle Inspira SCM 375CC breast implants and will be performed in Irvine, California. This award was made without set-aside designation, reflecting Allergan's position as a specialized supplier of these medical devices to federal...
- SPE2DE23D0008Indefinite Delivery Contract
- SPE2DE23D0008-SPE2D626F63G2Delivery Order
On December 8, 2025, the Defense Logistics Agency (DLA) Medical Supply Chain awarded a $3,807 fixed-price delivery order with economic price adjustment to Allergan USA Inc. for Natrelle Inspira SCF 385CC breast implants. This delivery order represents a child contract issued under Allergan's larger Indefinite Delivery Vehicle (IDV) agreement, a $13.5 million IDV for Natrelle breast implants and surgical devices established on December 8, 2022. The award was made without a set-aside designation, reflecting Allergan's status as a sole-source provider of these specialized medical devices to the federal government. The place of performance is located in Irvine, California, with an ultimate completion date of December 31, 2025. Allergan USA Inc., a subsidiary of AbbVie Inc., serves as the sole prime contractor on this award and has established itself as the critical supplier of breast implants to military treatment facilities, Veterans Affairs hospitals, and Indian Health Service centers. The company's federal contracting activity focuses exclusively on providing specialized reconstructive and aesthetic surgical devices to the Department of Defense through the DLA Troop Support Medical division. Allergan's IDV contracts enable electronic ordering and fulfillment of products across DoD research centers, hospitals, and clinics while providing on-site product support from Allergan representatives to ensure timely availability for surgical procedures supporting military members, veterans, and Native American populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 12/7/25 |